"Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A general term for various neoplastic diseases of the lymphoid tissue.
Descriptor ID |
D008223
|
MeSH Number(s) |
C04.557.386 C15.604.515.569 C20.683.515.761
|
Concept/Terms |
Lymphoma- Lymphoma
- Lymphomas
- Sarcoma, Germinoblastic
- Germinoblastic Sarcoma
- Germinoblastic Sarcomas
- Sarcomas, Germinoblastic
- Reticulolymphosarcoma
- Reticulolymphosarcomas
- Germinoblastoma
- Germinoblastomas
- Lymphoma, Malignant
- Lymphomas, Malignant
- Malignant Lymphoma
- Malignant Lymphomas
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma".
This graph shows the total number of publications written about "Lymphoma" by people in this website by year, and whether "Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 11 | 7 | 18 |
1995 | 11 | 4 | 15 |
1996 | 13 | 6 | 19 |
1997 | 4 | 8 | 12 |
1998 | 6 | 3 | 9 |
1999 | 7 | 6 | 13 |
2000 | 12 | 6 | 18 |
2001 | 3 | 2 | 5 |
2002 | 11 | 6 | 17 |
2003 | 13 | 6 | 19 |
2004 | 16 | 3 | 19 |
2005 | 16 | 8 | 24 |
2006 | 14 | 6 | 20 |
2007 | 15 | 7 | 22 |
2008 | 11 | 4 | 15 |
2009 | 17 | 5 | 22 |
2010 | 15 | 5 | 20 |
2011 | 19 | 8 | 27 |
2012 | 16 | 4 | 20 |
2013 | 14 | 1 | 15 |
2014 | 22 | 7 | 29 |
2015 | 30 | 0 | 30 |
2016 | 26 | 3 | 29 |
2017 | 27 | 4 | 31 |
2018 | 15 | 2 | 17 |
2019 | 18 | 5 | 23 |
2020 | 16 | 1 | 17 |
2021 | 23 | 1 | 24 |
2022 | 17 | 1 | 18 |
2023 | 21 | 0 | 21 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma" by people in Profiles.
-
Systematic review of mortality and survival rates for APDS. Clin Exp Med. 2024 Jan 27; 24(1):17.
-
Fine-needle aspiration?of amyloidoma: A critical analysis. Cancer Cytopathol. 2024 Mar; 132(3):179-185.
-
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy. Cytotherapy. 2024 Mar; 26(3):261-265.
-
Predictive and prognostic molecular biomarkers in lymphomas. Pathology. 2024 Mar; 56(2):239-258.
-
Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma. Cell Death Dis. 2023 11 25; 14(11):771.
-
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol. 2023 11 09; 16(1):111.
-
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. J Natl Cancer Inst. 2023 11 08; 115(11):1337-1354.
-
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells. Int J Mol Sci. 2023 Oct 31; 24(21).
-
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function. Br J Haematol. 2024 01; 204(1):e11-e16.
-
An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy. Blood Adv. 2023 09 26; 7(18):5480-5484.